Screening Novel Format Antibodies to Design Bispecific ADCs that Address Target Heterogeneity
Screening Novel Format Antibodies to Design Bispecific ADCs that Address Target Heterogeneity
TriTCE Co-Stim: A next generation trispecific T cell engager platform with integrated CD28 costimulation, engineered to improve T cell function and antitumor responses in hard-to-treat cancers
TriTCE Co-Stim: A next generation trispecific T cell engager platform with integrated CD28 costimulation, engineered to improve T cell function and antitumor responses in hard-to-treat cancers
Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)
Optimization of purine-based TLR7 agonists as payloads for immune-stimulating antibody conjugates (ISACs)
Engineering and Preclinical Development of ZW171: A 2+1 Format Anti-MSLN T Cell Engager
Engineering and Preclinical Development of ZW171: A 2+1 Format Anti-MSLN T Cell Engager
TriTCE Co-Stim, Next Generation Co-Stimulatory Trispecific T cell Engagers for the Treatment of Solid Tumors
TriTCE Co-Stim, Next Generation Co-Stimulatory Trispecific T cell Engagers for the Treatment of Solid Tumors
Zymeworks Topoisomerase 1 Inhibitor ADC Platform: From Concept to Pipeline
Zymeworks Topoisomerase 1 Inhibitor ADC Platform: From Concept to Pipeline
